Birch Grove Capital LP - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is and the CUSIP is 012423AB5. A total of 18 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Birch Grove Capital LP ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q1 2017$6,595,000
-40.4%
6,000,000
-29.4%
3.62%
-62.7%
Q4 2016$11,071,000
+9.8%
8,500,0000.0%9.71%
+2.7%
Q3 2016$10,083,000
+15.2%
8,500,0000.0%9.46%
+105.5%
Q2 2016$8,750,0008,500,0004.60%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q2 2017
NameSharesValueWeighting ↓
Context Capital Management, LLC 5,625,000$5,815,0006.76%
ALTEGRIS ADVISORS, L.L.C. 500,000$512,0005.92%
Birch Grove Capital LP 8,500,000$8,750,0004.60%
Mohican Financial Management, LLC 3,700,000$3,790,0003.42%
Verition Fund Management LLC 4,500,000$4,632,0000.59%
BASSO CAPITAL MANAGEMENT, L.P. 2,810,000$2,893,0000.45%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 20,000,000$20,688,000,0000.45%
SSI INVESTMENT MANAGEMENT LLC 3,364,000$3,446,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 15,000,000$15,510,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 5,016,000$5,182,0000.19%
View complete list of ALBANY MOLECULAR RESH INC shareholders